Emulate, Inc., secured $36 million in Series C financing led by Founders Fund, as well as new investors ALS Investment Fund, SciFi VC, members of GlassWall Syndicate Association, and existing investors. Emulate’s automated, lab-ready Human Emulation System is comprised of Organ-Chips, instrumentation, and software applications.